OA11758A - Regulation of anaesthesia. - Google Patents

Regulation of anaesthesia. Download PDF

Info

Publication number
OA11758A
OA11758A OA1200100203A OA1200100203A OA11758A OA 11758 A OA11758 A OA 11758A OA 1200100203 A OA1200100203 A OA 1200100203A OA 1200100203 A OA1200100203 A OA 1200100203A OA 11758 A OA11758 A OA 11758A
Authority
OA
OAPI
Prior art keywords
dsip
anaesthesia
anaesthetic
sleep
delta
Prior art date
Application number
OA1200100203A
Other languages
English (en)
Inventor
Michael Alkire
Jim Fallon
Richard Haier
Christopher John Doug Pomfrett
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9902469.7A external-priority patent/GB9902469D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Publication of OA11758A publication Critical patent/OA11758A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
OA1200100203A 1999-02-05 2000-02-01 Regulation of anaesthesia. OA11758A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9902469.7A GB9902469D0 (en) 1999-02-05 1999-02-05 Brain metabolism
US12032699P 1999-02-17 1999-02-17
US15566199P 1999-09-24 1999-09-24

Publications (1)

Publication Number Publication Date
OA11758A true OA11758A (en) 2005-07-19

Family

ID=27269636

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200100203A OA11758A (en) 1999-02-05 2000-02-01 Regulation of anaesthesia.

Country Status (15)

Country Link
EP (1) EP1148887A2 (zh)
JP (1) JP2002536337A (zh)
KR (1) KR20010101992A (zh)
CN (1) CN1346278A (zh)
AP (1) AP2001002245A0 (zh)
AU (1) AU2445900A (zh)
BR (1) BR0008046A (zh)
CA (1) CA2360124A1 (zh)
ID (1) ID30518A (zh)
IL (1) IL144572A0 (zh)
MX (1) MXPA01007949A (zh)
NO (1) NO20013795D0 (zh)
OA (1) OA11758A (zh)
TR (1) TR200102265T2 (zh)
WO (1) WO2000045832A2 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275308A1 (en) * 2001-07-13 2003-01-15 The Procter & Gamble Company Food composition offering stress relaxation to mammals
KR20100056524A (ko) * 2007-09-11 2010-05-27 몬도바이오테크 래보래토리즈 아게 치료제로서의 펩티드 배합물 티모신 베타 ４ 및 델타 수면 유도 펩티드의 용도
GB201116271D0 (en) * 2011-09-21 2011-11-02 Univ Cardiff Dispersion anaesthetic device
CN108376559B (zh) * 2018-02-28 2020-10-16 复旦大学附属中山医院 乙醛脱氢酶2基因型在麻醉剂量计算中的应用
CN112535727A (zh) * 2020-12-24 2021-03-23 安域生物制药(杭州)有限公司 一种具有睡眠改善作用的短肽凝胶及其制备方法
CN112908454B (zh) * 2021-02-26 2023-08-29 西安交通大学口腔医院 一种智能保管麻醉剂的方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH634331A5 (de) * 1977-06-30 1983-01-31 Hoffmann La Roche Phosphorylierte nonapeptide und verfahren zu deren herstellung.
CA1188989A (en) * 1981-05-21 1985-06-18 Richard R. Scherschlicht Nonapeptide for the treatment of drug withdrawal symptoms
IT1251544B (it) * 1991-05-13 1995-05-17 Gabriele Biella Composizioni farmaceutiche attive nella terapia dei disturbi del sonno comprendenti melatonina o un suo derivato in associazione con un derivato benzodiazepinico
RU2104717C1 (ru) * 1995-07-07 1998-02-20 Новокузнецкий государственный институт усовершенствования врачей Способ анестезии при операциях у больных с синдромом лериша

Also Published As

Publication number Publication date
NO20013795L (no) 2001-08-02
CN1346278A (zh) 2002-04-24
IL144572A0 (en) 2002-05-23
MXPA01007949A (es) 2003-06-04
JP2002536337A (ja) 2002-10-29
ID30518A (id) 2001-12-13
WO2000045832A2 (en) 2000-08-10
NO20013795D0 (no) 2001-08-02
KR20010101992A (ko) 2001-11-15
CA2360124A1 (en) 2000-08-10
TR200102265T2 (tr) 2001-12-21
AP2001002245A0 (en) 2001-09-30
BR0008046A (pt) 2001-11-06
AU2445900A (en) 2000-08-25
EP1148887A2 (en) 2001-10-31
WO2000045832A3 (en) 2000-11-30

Similar Documents

Publication Publication Date Title
Gurbet et al. Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements
US6562855B1 (en) Anaesthetic formulation comprising an NMDA-antagoinst and an alpha-2 adrenergic agonist
Thomas et al. Epidural dexamethasone reduces postoperative pain and analgesic requirements
AU2001273256A1 (en) Methods of producing weight loss and treatment of obesity
JP2003529541A6 (ja) ＮＭＤＡ拮抗薬とα２アドレナリン作用薬とを含む麻酔製剤
EP1305034A2 (en) Methods of producing weight loss and treatment of obesity
US5432176A (en) Method of retarding the progression of chronic renal failure
WO1999007224A1 (en) Compositions and methods for treating diabetes
Rattan et al. Identification and localization of opioid receptors in the opossum lower esophageal sphincter.
US20040176274A1 (en) Analgesic methods using endothelin receptor ligands
Tortorici et al. Anti‐nociception induced by systemic or PAG‐microinjected lysine‐acetylsalicylate in rats. Effects on tail‐flick related activity of medullary off‐and on‐cells
SK138095A3 (en) Transdermal therapeutic system for the administration of serotonin agonists
US6281222B1 (en) Compositions and method for treatment of acetaminophen intoxication
Freedman et al. Vasoconstrictor effects in spinal cord of the substance P antagonist [D-ARG1, D-TRP7, 9, LEU11] substance P (spantide) and somatostatin and interaction with thyrotropin releasing hormone
OA11758A (en) Regulation of anaesthesia.
Van Wimersma Greidanus et al. Vasopressin and oxytocin their presence in the central nervous system and their functional significance in brain processes related to behaviour and memory
Raasch et al. Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors?
Jaakola et al. Intramuscular dexmedetomidine premedication—an alternative to midazolam‐fentanyl‐combination in elective hysterectomy?
Toppila et al. Intracerebroventricular and locus coeruleus microinjections of somatostatin antagonist decrease REM sleep in rats
ZA200106256B (en) Regulation of anaesthesia.
Seymour et al. In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors
Paczwa et al. Enhancement of central pressor effect of AVP in SHR and WKY rats by intracranial NG-nitro-L-arginine
AU2001273228A1 (en) Methods of treatment comprising administration of substance P
Collin et al. Feedback inhibition of met‐enkephalin release from the rat spinal cord in vivo
Yoshida et al. Effect of fentanyl citrate analgesia on glucose production following trauma in rats